P. Vorwerk et al., INSULIN AND IGF BINDING BY IGFBP-3 FRAGMENTS DERIVED FROM PROTEOLYSIS, BACULORVIRUS EXPRESSION AND NORMAL HUMAN URINE, The Journal of clinical endocrinology and metabolism, 83(4), 1998, pp. 1392-1395
Recombinant human IGFBP-3 was protelysed with different concentrations
of plasmin for various periods of time. The major IGFBP-3 fragment re
sulting from this digestion migrated at ca. 15 kDa in nonreducing SDS-
PAGE. Following the identification of this fragment as an N-terminal I
GFBP-3 fragment, by use of N-terminus-specific monoclonal antibody and
amino acid sequence analysis, we constructed and expressed a similar
fragment in a baculovirus expression system. The fragments resulting f
rom plasmin digestion. as well as the baculovirus-expressed recombinan
t human IGFBP-3(1-97), retain weak IGF binding and show specific insul
in binding on cross-linking and westem ligand blot. RhIGFBP-3(1-97) ca
n inhibit insulin receptor autophosphorylation in insulin receptor-ove
rexpressing NIH 3T3 cells. insulin and IGF binding to IGFBP-3 fragment
s could be further demonstrated in normal urine. These data indicate t
he physiological significance of IGFBP-3 fragments derived from proteo
lysis in vivo.